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ABSTRACT Dystrophin has been shown to be associated in cells with actin bundles. Dys-246, an N-terminal recombinant
protein encoding the first 246 residues of dystrophin, includes two calponin-homology (CH) domains, and is similar to a large
class of F-actin cross-linking proteins including -actinin, fimbrin, and spectrin. It has been shown that expression or
microinjection of amino-terminal fragments of dystrophin or the closely related utrophin resulted in the localization of these
protein domains to actin bundles. However, in vitro studies have failed to detect any bundling of actin by either intact
dystrophin or Dys-246. We show here that the structure of F-actin can be modulated so that there are two modes of Dys-246
binding, from bundling actin filaments to only binding to single filaments. The changes in F-actin structure that allow Dys-246
to bundle filaments are induced by covalent modification of Cys-374, proteolytic cleavage of F-actin’s C-terminus, mutation
of yeast actin’s N-terminus, and different buffers. The present results suggest that F-actin’s structural state can have a large
influence on the nature of actin’s interaction with other proteins, and these different states need to be considered when
conducting in vitro assays.
INTRODUCTION
Dystrophin is the 3685-residue protein product of the gene
defective in Duchenne muscular dystrophy, and it is found
in the muscle membrane cytoskeleton (Bonilla et al., 1988).
Dystrophin shares significant homology with actin-binding
proteins such as -actinin and spectrin, and the amino-
terminus of dystrophin has been shown to be functionally
homologous to the amino-terminus of -actinin (Hemmings
et al., 1992). Dystrophin has been shown to be associated in
cells with actin bundles, and is thought to form a structural
linkage between the actin-based cytoskeleton and the extra-
cellular matrix (Tidball and Law, 1991; Belkin and Burr-
idge, 1995). The two CH domains within the N-terminal
region of dystrophin may form a single actin-binding do-
main, based upon analysis of related proteins (Puius et al.,
1998; Stradal et al., 1998). It has been shown using electron
microscopy (Tidball and Law, 1991) and immunofluores-
cence (Belkin and Burridge, 1995) that dystrophin is asso-
ciated with actin bundles located near the sarcolemmal
membrane, and it has been suggested that dystrophin may
form antiparallel dimers that cross-link different actin fila-
ments (Ahn and Kunkel, 1993).
Dys-246, an N-terminal recombinant protein encoding
the first 246 residues of dystrophin (Rybakova et al., 1996;
Renley et al., 1998), includes two calponin-homology (CH)
domains, and is similar to a large class of F-actin cross-
linking proteins including -actinin, fimbrin, and spectrin
(Matsudaira, 1991; Puius et al., 1998). It has been shown
that this fragment binds to F-actin in vitro (Rybakova et al.,
1996; Renley et al., 1998). Expression or microinjection of
amino-terminal fragments of dystrophin (Hemmings et al.,
1992) or the closely related utrophin (Winder et al., 1995)
resulted in the localization of these protein domains to actin
bundles. However, neither intact dystrophin nor N-terminal
recombinant fragments have been observed to bundle actin
filaments (Rybakova et al., 1996; Rybakova and Ervasti,
unpublished results) in vitro. By analogy with actin cross-
linking proteins such as -actinin, it would be expected that
actin bundling would be due to the formation of a dystro-
phin dimer. The possible dimerization of either intact dys-
trophin or N-terminal fragments of dystrophin has been
controversial. Dimers of dystrophin were observed by elec-
tron microscopy (Pons et al., 1990), but not observed by
immunoprecipitation and blot overlays (Chan and Kunkel,
1997) or gel filtration and analytical ultracentrifugation
(Rybakova and Ervasti, 1997). A recent study has found
dimers of the N-terminal actin-binding domain both in
crystals and in solution (Norwood et al., 2000).
METHODS
Actin prepared from rabbit skeletal muscle was purified on either a Seph-
adex G-200 column or a Superdex-200 column using the AKTA-Explorer
system (Pharmacia, Uppsala, Sweden). G-Ca2-actin at 0.5 mg/ml was
polymerized by 0.1 M KCl, and F-actin was diluted to 3 M by 100 mM
KCl, 10 mM Tris-HCl, Hepes, Mops, or Pipes buffer, pH 7.7, at room
temperature. Trypsin-cleaved actin and erythrosin-actin were prepared as
described (Orlova and Egelman, 1995; Orlova et al., 1995). Yeast actin was
purified from wild-type and 4Ac-mutant yeast cells using a DNase I
column method, as described (Prochniewicz and Thomas, 1999). The 4Ac
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mutant was a gift from Dr. Peter Rubenstein, and in this mutant three
amino-terminal residues have been replaced by four residues from skeletal
muscle actin (Cook et al., 1993).
Dys-246 was expressed and purified as previously described (Rybakova
et al., 1996), but was step-dialyzed in buffer A (10 mM Tris-HCl, pH 8.0)
containing 500 mM NaCl and 0.1 mM dithiothreitol, followed by buffer A
containing 0.1 M NaCl and 1 mM iodoacetamide, and finally into buffer A
containing 0.1 M NaCl. After concentration in a Centriplus, the Dys-246
was centrifuged immediately before use for 30 min at 100,000  g to
remove aggregated material.
Different actin samples (3 M) in either Tris or Hepes buffer were
incubated with Dys-246 (3–12 M) at room temperature for 10–20 min.
Sample mixtures were applied to a grid and stained with 1% uranyl acetate,
and then examined in a JEOL 1200 EXII electron microscope at an
accelerating voltage of 80 keV and a nominal magnification of 30,000.
Samples of the actin/Dys-246 complexes were examined directly, without
any centrifugation of the mixtures.
Dys-246 binding to actin was measured using high- and low-speed
sedimentation assays (Rybakova et al., 1996). Various amounts of Dys-246
were incubated at room temperature for 30 min with 3–6 M F-actin in 10
mM Tris or Hepes buffer, 0.1 M KCl, pH 7.6, and centrifuged for 20 min
at either 20,000 or 100,000  g. The supernatants and resuspended pellets
were electrophoresed in SDS on polyacrylamide gels, and these were
stained with Coomassie blue and analyzed densitometrically using a Bio-
Rad GS-670 imaging densitometer. Intensities of the scanned bands were
quantitated by volume integration after background subtraction.
RESULTS
We have found that the mode of dystrophin’s binding to
F-actin can be switched between binding to isolated actin
filaments and bundling of many filaments. Fig. 1 a shows an
electron micrograph of skeletal muscle actin filaments in-
cubated with Dys-246 in Tris buffer, where only the random
binding of Dys-246 to single filaments can be observed. It
has previously been shown that the dissociation constant for
Dys-246 binding to actin in Tris buffer is 14 M (Renley
et al., 1998). Under the conditions used (3 M actin, 6 M
Dys-246) we would expect with this dissociation constant
that only 13% of the Dys-246 molecules would be bound
to actin, and that most actin subunits would not have a
Dys-246 bound. Thus, the large background of unbound
Dys-246 molecules prevents one from easily observing the
small number of bound ones.
Labeling of actin by the covalent attachment of erythrosin
to Cys-374 has been shown to induce a change in F-actin
structure (Orlova et al., 1995). When erythrosin-labeled
F-actin is incubated with Dys-246 in Tris buffer, under
conditions where no bundling is observed for unmodified
F-actin (Fig. 1 a), bundling of the actin filaments occurs
(Fig. 1 b).
The cleavage of two C-terminal residues from F-actin by
trypsin (Fig. 1 c) also induces a conformational change in
the filament (O’Donoghue et al., 1992; Orlova et al., 1995).
We find (Fig. 1 d) that Dys-246 bundles trypsin-cleaved
actin in Tris buffer, while no bundling occurs for wild-type
filaments under the same conditions (Fig. 1 a), and no
regular bundling occurs for the trypsin-cleaved actin fila-
ments alone (Fig. 1 c).
When these same experiments with unmodified skeletal
muscle actin are done in Hepes buffer, bundling of F-actin
is seen (Fig. 1 f). We can exclude possible pH effects in the
change from Tris to Hepes due to temperature or concen-
tration changes, since all experiments (and buffer prepara-
tions) were done at the same temperature, and the buffer
concentration was held relatively constant. The effect would
be consistent with a change in either F-actin or Dys-246 due
to the change in buffer. However, the other experiments
show that the change must be occurring in the F-actin.
Consistent with this, we find that no bundling of wild-
type yeast F-actin occurs with Dys-246 in Tris buffer (Fig.
1 g), but extensive bundling occurs with wild-type yeast
actin in Hepes, Mops, or Pipes buffers (data not shown). A
preliminary study shows extensive bundling in Tris buffer
with a yeast mutant actin (4Ac) (Fig. 1 h), suggesting that it
is a change in actin’s structure that is responsible for the
switch between these two modes of interaction.
The regular lateral spacing of the actin filaments induced
by Dys-246 can be seen in Fig. 2, arguing against a non-
specific effect of Dys-246 on the actin, or an actin-actin
interaction such as that which occurs at high concentrations
of divalent cations. When only two actin filaments are
linked (Fig. 2 a), the cross-bridges are seen in the plane of
the two filaments, spaced axially by roughly the distance of
the actin crossovers, and the filaments are spaced laterally
by 160 Å. When more actin filaments are cross-linked
into three-dimensional bundles (Fig. 2, b, c, and d), more
closely spaced cross-bridges are seen in projection. This
follows from the general rules for cross-bridging actin fil-
aments (DeRosier and Tilney, 1982). Due to the fact that
these bundles are not highly ordered, regular transverse
stripes are not seen in larger bundles (Fig. 2 e) that may
contain 10 actin filaments.
Could the observed bundling be an artifact of specimen
preparation for electron microscopy? We have used a low-
speed cosedimentation assay to quantitate the amount of
actin bound with the fragment in bundles under different
conditions. We found (Fig. 3) that no significant fraction
(2.9%) of the skeletal muscle actin in Tris buffer was in
the pellet after low-speed centrifugation (20,000  g for 20
min), as has been shown previously (Rybakova et al., 1996).
But this fraction increased to 29% when Hepes buffer was
used and 60% when erythrosin-modified actin was used in
Tris buffer (Fig. 3). Previous control experiments showed
that Dys-246 bound to F-actin in Tris buffer (measured at
high g) with a stoichiometry of 1:1 and an apparent Kd of 14
M (Renley et al., 1998). Given a total actin concentration
of 6 M, and a total Dys-246 concentration of 6 M (the
concentrations used for the experiments shown in Fig. 3),
the 14 M dissociation constant predicts that the concen-
tration of free actin (not bound by Dys-246) will be 4.5 M,
or that only 25% of the actin is bound by Dys-246. Although
quantitatively predicting the amount of actin filaments that
would be bound in bundles is difficult or impossible, the
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FIGURE 1 F-actin’s structure can be switched from
a state where Dys-246 binds only to single filaments (a,
e, g), to a state where it bundles actin filaments (b, d, f,
h). Skeletal muscle actin (3 M) was incubated with
Dys-246 (6 M) in 0.1 M KCl and 10 mM Tris-HCl,
pH 7.7. There is a random binding of Dys-246 to single
actin filaments in Tris buffer (a), which can be seen
more easily in the higher-magnification inset. When the
actin filaments are covalently modified by the attach-
ment of erythrosin at Cys-374 (Orlova et al., 1995, they
are bundled by Dys-246 under the same conditions (b).
Tryptically cleaved actin filaments are more fragile
than normal filaments and tend to form small aggre-
gates (c), but are bundled by Dys-246 in Tris buffer (d),
under the same conditions where wild-type filaments
are not bundled (a, e). When Tris buffer (e) is replaced
by Hepes, skeletal muscle actin filaments are now
bundled (f). Wild-type yeast actin (3 M) was incu-
bated with Dys-246 (7 M) in 10 mM Tris buffer, and
random binding is found to single filaments (g). Re-
placement of the first four amino acids with residues
from skeletal muscle actin leads to a change in the
mode of binding (h), where Dys-246 now cross-links
the actin filaments into bundles. The scale bar in (a) is
1000 Å, and 500 Å within the inset.
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amount of actin seen in the low-speed spin pellet (bundled
by Dys-246) is consistent with the measured affinity of
Dys-246 for actin. The increased amount of actin seen in the
erythrosin-actin pellet might be due to either an increased
affinity of erythrosin-actin for Dys-246 or a greater coop-
erativity in bundle formation.
More importantly, could the bundling, seen in Hepes
buffer, with erythrosin-actin, with tryptic-cleaved actin, and
with the yeast 4Ac mutant, be due to an increase in the
affinity of Dys-246 for actin? That is, could these changes
in actin be associated with a greatly increased affinity of
Dys-246 for actin, such that no bundling is seen when the
binding is weak, but extensive bundling is seen when the
binding is stronger? We have measured the binding of
Dys-246 to F-actin in both Tris and Hepes buffers, over a
concentration range covering the EM experiments, using a
high-speed sedimentation assay (Fig. 4). It can be seen that
there is no significant change in the binding curves between
the Tris and Hepes buffers, and that these curves are both in
excellent agreement with the full binding isotherms deter-
mined by Renley et al. (1998). The combined data in Fig. 3
and Fig. 4 therefore show that under conditions where the
intrinsic affinity of Dys-246 is remaining relatively con-
stant, the mode of binding to F-actin can change from
binding isolated filaments to bundling F-actin.
DISCUSSION
Although the effect of the change from Tris to Hepes (or
Mops or Pipes) buffer could be on either F-actin or Dys-
246, or both, the erythrosin modification, the tryptic cleav-
FIGURE 2 The specific nature of the Dys-246 cross-links can be seen. Skeletal muscle actin has been labeled with erythrosin and incubated with
Dys-246. Individual cross-links between two filaments are clearly visible in (a), forming a ladder in the plane of the image. In b, c, and d the transverse
bands produced by the Dys-246 cross-bridges can be seen in small three-dimensional bundles. Due to the disordered nature of these bundles, regular
transverse bands are not seen in larger, three-dimensional bundles (e). The scale bar in (c) is 500 Å.
FIGURE 3 Low-speed cosedimentation of Dys-246 with different actins. Coomassie blue-stained SDS gels are shown of supernatants (S) and pellets (P)
after centrifugation at 20,000  g for 20 min of 6 M skeletal muscle actin alone (a, c, e) and with 6 M Dys-246 (b, d) in 10 mM Tris (a, b) or Hepes
(c, d) buffer, 0.1 M KCl, pH 7.6. The experiments with erythrosin-modified skeletal muscle actin (ErAct) (e, f) were done in Tris buffer, with both proteins
present at 3 M. Similar, very small amounts of Dys-246 pelleted in the absence of actin at low speed in both Hepes and Tris.
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age, and the 4Ac mutation can only be changing the struc-
ture of F-actin. Previous observations have suggested that
actin’s structure could be modified by trinitrophenylation of
lysines using a sulfonic acid derivative (Muhlrad, 1968),
and Hepes, Mops, and Pipes contain a related aminosulfon-
ate. It has been directly shown that the aminosulfonate
present in Hepes can change the properties of the gap
junction protein connexin (Bevans and Harris, 1999). We
have used two other sulfonic acid derivative buffers, Mops
and Pipes, and observed the same results: skeletal muscle
actin and wild-type yeast actin polymerized in these buffers
formed bundles in the presence of the fragment. A recon-
struction of F-actin in Hepes has failed to detect any sig-
nificant conformational change at low resolution (Orlova
and Egelman, unpublished results), while significant con-
formational changes were detected after erythrosin modifi-
cation and tryptic cleavage (Orlova et al., 1995). Thus, there
may be a number of different conformational states that
allow for Dys-246 to cross-link actin. The conformational
change in actin that allows this cross-linking to occur may
be very small, and not seen at low resolution.
An interesting possibility is that this conformational
change allows for a dimerization of Dys-246 to occur, so
that the cross-link formed between two actin filaments
involves a dimer of Dys-246. This would be consistent with
the observed failure to observe a dimerization of amino-
terminal fragments alone (Chan and Kunkel, 1997). How-
ever, a more recent report has observed dimers of an amino-
terminal fragment of dystrophin both in crystals and in
solution (Norwood et al., 2000), suggesting that dimeriza-
tion of this fragment may be very sensitive to conditions. A
dimer of Dys-246 would also be consistent with the span of
the cross-link between two actin filaments (Fig. 2 a). A
single Dys-246 molecule, based upon homology to fimbrin
(Puius et al., 1998), would be expected to be fairly compact.
Although it is difficult to quantify the cross-bridge size
given the disorder and the inability to average, the mass of
the cross-bridge seen between two actin filaments (Fig. 2 a)
appears too large for a single 27-kDa molecule. An actin
subunit within a filament is 42 kDa, and the cross-bridges
appear to be larger than this. The crystal structure of an
equivalent tandem calponin homology domain from utro-
phin reveals a head-to-tail dimerization (Keep et al., 1999),
but the structure also suggests a great conformational plas-
ticity that might give rise to polymorphic interactions with
actin. Such plasticity has been invoked in trying to model
the stoichiometric binding of the actin-binding domain from
utrophin to F-actin (Moores et al., 2000). They suggested
that highly related proteins in the fimbrin-utrophin-dystro-
phin family might have very diverse mechanisms of actin
binding based upon rearrangements of the CH domains. Our
results suggest that an even greater degree of diversity may
arise when actin’s structure is modulated by many different
means. Although Moores et al. (2000) suggested an in-
duced-fit mechanism, in which utrophin induces a confor-
mational change within the actin filament, and association
with the actin filament stabilizes a different conformation of
utrophin’s actin-binding domain, our observations suggest
that different conformations of F-actin may modulate the
ability of Dys-246 to cross-link actin.
CONCLUSIONS
What are the implications for these in vitro results, since we
do not believe that the cell modifies F-actin by any of the
means discussed? It has previously been shown that the
nucleation of actin filaments by the actin-binding protein
gelsolin induces a long-range conformational change in the
actin filament (Orlova et al., 1995; Prochniewicz et al.,
1996; Suzuki and Ito, 1996; Khaitlina and Hinssen, 1997;
Ressad et al., 1998). Since there is good reason to believe
that all actin filaments in the cell are nucleated by other
proteins, many in association with membranes or or-
ganelles, it is possible that the cell can control by the state
of individual actin filaments by the use of different nucle-
ation proteins. An interesting puzzle has been that dystro-
phin is localized to the sarcolemma, possibly through a
direct interaction with actin, and is not found associated
with skeletal muscle actin, while the in vitro affinities of
Dys-246 are similar for both muscle and nonmuscle iso-
FIGURE 4 A high-speed (100,000  g) sedimentation experiment
shows that over the concentration range used for EM experiments, the
binding of Dys-246 to actin in Tris (solid circles) and Hepes (open circles)
buffers is nearly indistinguishable. No difference was seen in the amount
of Dys-246 that pelleted in the absence of actin between Tris and Hepes.
Thus, the change in the mode of binding, observed by both EM (Fig. 1) and
low-speed sedimentation (Fig. 3) cannot be explained by a large change in
the affinity of Dys-246 for actin.
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forms of actin (Renley et al., 1998). Our results suggest that
the different binding modes of dystrophin may be regulated
more by the structural state of the actin filament than by the
isoform involved.
Most importantly, the ability of F-actin to exist in mul-
tiple conformational states complicates in vitro studies of
the interaction between actin and other proteins. The ques-
tion of what structural states of F-actin exist in vivo remains
to be answered, and whether the cell modulates these states
to control the interactions with other proteins is an interest-
ing area of speculation.
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